Regulatory Status FDA, WADA anti-doping, and compounding status provided for research context
A 2024 study published in PNAS investigated the bioenergetics of peripheral blood lymphocytes in patients with ME/CFS and Long COVID
Systemic inflammatory response syndrome (SIRS) following unregulated IV administration, presenting with fever above 41 degrees Celsius, acute liver injury, and clotting abnormalities, is also documented in a 2025 case report
Cardioprotective effects of epigallocatechin-3-gallate against doxorubicin-induced cardiomyocyte injury
Cells were extracted from the dorsal skin of newborn mice within 24 h after birth, and the dermis and epidermis were separated by floating the dorsal skin in 0.25% trypsin (#150057, Gibco, USA) solution at 4C overnight